Skip to main content

Afeyan Noubar's Form 4 filing

Evelo Biosciences, Inc.EVLO · filed Jul 13, 2023

Accession no.
0000950170-23-032871
Filed
Jul 13, 2023, 5:15 PM ET
Trade date
Jul 11, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market purchases total $12.5M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Afeyan NoubarCIK 000122201210% Owner
Flagship Pioneering, LLCCIK 000140024010% Owner
Flagship Ventures Fund IV, L.P.CIK 000150355910% Owner
Flagship Ventures Fund IV General Partner LLCCIK 000150805110% Owner
Nutritional Health LTP Fund General Partner LLCCIK 000178095110% Owner
Nutritional Health LTP Fund, L.P.CIK 000178095610% Owner
Flagship Pioneering Fund VII, L.P.CIK 000180591610% Owner
Flagship Pioneering Fund VII General Partner LLCCIK 000180591710% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 11, 2023Common StockPPurchaseAcquired+1,082,251$2.31+$2,499,999.811,461,795Indirect
Jul 11, 2023Common StockPPurchaseAcquired+1,082,251$2.31+$2,499,999.811,493,241Indirect
Jul 11, 2023Common StockPPurchaseAcquired+3,246,753$2.31+$7,499,999.433,931,685Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

On June 29, 2023, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The share amounts reported herein have been adjusted to reflect the Reverse Stock Split.

Read the full filing on SEC EDGAR (opens in a new tab)